Cargando…

“Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice

BACKGROUND: In response to the COVID-19 pandemic, many pharmacy-based or pharmacist-delivered services were introduced or amended to mitigate the pandemic's health and social impact. This happened within the context of pharmacists seeking more opportunities to increase their clinical responsibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Kellia, Thow, Anne Marie, Bero, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985421/
https://www.ncbi.nlm.nih.gov/pubmed/35414485
http://dx.doi.org/10.1016/j.sapharm.2022.03.045
_version_ 1784682362711310336
author Chiu, Kellia
Thow, Anne Marie
Bero, Lisa
author_facet Chiu, Kellia
Thow, Anne Marie
Bero, Lisa
author_sort Chiu, Kellia
collection PubMed
description BACKGROUND: In response to the COVID-19 pandemic, many pharmacy-based or pharmacist-delivered services were introduced or amended to mitigate the pandemic's health and social impact. This happened within the context of pharmacists seeking more opportunities to increase their clinical responsibilities and play a larger role in primary care. Objective(s): To analyse the policymaking context and pharmacy responses to COVID-19 that enable or constrain the expansion of pharmacists’ scope of practice. METHODS: This study is a policy analysis of documentary data detailing changes in pharmacy policy in Australia, drawing on a “policy space analysis” framework to identify opportunities and constraints to policy reform. Data were collected from news for health professionals; federal/jurisdictional legislation and media releases; and guidelines and directives from government health departments and agencies. Changes to pharmacy practice were identified and classified according to type. For each change, potential opportunities and constraints for expanding pharmacists’ scope of practice were identified. RESULTS: Four categories of changes were identified: medicines limits/restrictions; alternatives to paper prescriptions; public health measures; and community pharmacist-delivered services. Opportunities from the pandemic response that could expand scope of practice include the potential permanence of temporary measures that increase pharmacists' responsibilities; remuneration to legitimise services; political acknowledgement of medicines safety and access as a priority; and government need to quickly address crises. Constraints include the potential permanence of temporary measures that restrict pharmacists’ practice; negative perceptions of pharmacists from other clinicians; intra-professional disagreements regarding pharmacy-based services; and lack of pharmacist representation in institutional structures. CONCLUSIONS: This analysis demonstrates that the pandemic responses and policy context may facilitate expansion of pharmacists’ scope of practice, and identifies possible avenues to do so; it also highlights constraints that need to be further addressed to achieve this goal.
format Online
Article
Text
id pubmed-8985421
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89854212022-04-06 “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice Chiu, Kellia Thow, Anne Marie Bero, Lisa Res Social Adm Pharm Article BACKGROUND: In response to the COVID-19 pandemic, many pharmacy-based or pharmacist-delivered services were introduced or amended to mitigate the pandemic's health and social impact. This happened within the context of pharmacists seeking more opportunities to increase their clinical responsibilities and play a larger role in primary care. Objective(s): To analyse the policymaking context and pharmacy responses to COVID-19 that enable or constrain the expansion of pharmacists’ scope of practice. METHODS: This study is a policy analysis of documentary data detailing changes in pharmacy policy in Australia, drawing on a “policy space analysis” framework to identify opportunities and constraints to policy reform. Data were collected from news for health professionals; federal/jurisdictional legislation and media releases; and guidelines and directives from government health departments and agencies. Changes to pharmacy practice were identified and classified according to type. For each change, potential opportunities and constraints for expanding pharmacists’ scope of practice were identified. RESULTS: Four categories of changes were identified: medicines limits/restrictions; alternatives to paper prescriptions; public health measures; and community pharmacist-delivered services. Opportunities from the pandemic response that could expand scope of practice include the potential permanence of temporary measures that increase pharmacists' responsibilities; remuneration to legitimise services; political acknowledgement of medicines safety and access as a priority; and government need to quickly address crises. Constraints include the potential permanence of temporary measures that restrict pharmacists’ practice; negative perceptions of pharmacists from other clinicians; intra-professional disagreements regarding pharmacy-based services; and lack of pharmacist representation in institutional structures. CONCLUSIONS: This analysis demonstrates that the pandemic responses and policy context may facilitate expansion of pharmacists’ scope of practice, and identifies possible avenues to do so; it also highlights constraints that need to be further addressed to achieve this goal. Elsevier Inc. 2022-09 2022-04-06 /pmc/articles/PMC8985421/ /pubmed/35414485 http://dx.doi.org/10.1016/j.sapharm.2022.03.045 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chiu, Kellia
Thow, Anne Marie
Bero, Lisa
“Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title_full “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title_fullStr “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title_full_unstemmed “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title_short “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice
title_sort “never waste a good crisis”: opportunities and constraints from the covid-19 pandemic on pharmacists’ scope of practice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985421/
https://www.ncbi.nlm.nih.gov/pubmed/35414485
http://dx.doi.org/10.1016/j.sapharm.2022.03.045
work_keys_str_mv AT chiukellia neverwasteagoodcrisisopportunitiesandconstraintsfromthecovid19pandemiconpharmacistsscopeofpractice
AT thowannemarie neverwasteagoodcrisisopportunitiesandconstraintsfromthecovid19pandemiconpharmacistsscopeofpractice
AT berolisa neverwasteagoodcrisisopportunitiesandconstraintsfromthecovid19pandemiconpharmacistsscopeofpractice